Abstract
Background: Circular RNAs (circRNAs) have a vital role in the occurrence of numerous cancers. However, its function and pattern of expression in cervical cancer (CC) remain unclear. This research aims to investigate the hsa_circ_000002’s regulatory mechanism in CC.
Methods: Hsa_circ_0000021, miR-3940-3p, and KPNA2 expression levels were estimated through qRT-PCR. Nuclear/cytoplasmic separation was conducted to find the subcellular location of hsa_circ_0000021. Western blot was done to estimate the levels of KPNA2 protein. CCK-8, BrdU, wound healing, transwell, and tumor xenograft assays were performed to study how hsa_circ_0000021/miR-3940-3P/KPNA2 function affect CC. Hsa_circ_0000021’s targeting relationships with miR-3940-3p and KPNA2 were ascertained through RIP and luciferase experiments.
Results: Hsa_circ_0000021 and KPNA2 were overexpressed and inversely associated with the levels of miR-3940-3p in CC. Knocking down either hsa_circ_0000021 or KPNA2 repressed the growth of CC tumors as well as the proliferation, invasion, and migration of CC cells. Silencing miR-3940-3p promoted the malignant proliferation of CC cells. Regarding its mechanism, hsa_circ_0000021 affected the malignant CC cell proliferation via the sponging of miR-3940-3p, which targeted KPNA2.
Conclusion: Hsa_circ_0000021 regulates the miR-3940-3p/KPNA2 axis to promote CC occurrence. This potentially is a novel target for CC treatment.
Keywords: Hsa_circ_0000021, CC, MiR-3940-3p, KPNA2, CircRNAs, Genetics.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[http://dx.doi.org/10.1097/AOG.0b013e31829b61d6] [PMID: 23969811]
[http://dx.doi.org/10.1016/j.jinf.2012.10.024] [PMID: 23103285]
[http://dx.doi.org/10.1016/j.bpobgyn.2020.02.008] [PMID: 32291178]
[http://dx.doi.org/10.1099/jgv.0.001540] [PMID: 33427604]
[http://dx.doi.org/10.3389/fgene.2014.00234] [PMID: 25101115]
[http://dx.doi.org/10.1016/j.yexmp.2018.11.010] [PMID: 30471246]
[http://dx.doi.org/10.1007/s43032-019-00058-9] [PMID: 32046460]
[http://dx.doi.org/10.1186/s13027-019-0238-5] [PMID: 31832086]
[http://dx.doi.org/10.1186/s12885-019-5983-8] [PMID: 31391008]
[http://dx.doi.org/10.1007/s10620-020-06308-0] [PMID: 32394331]
[http://dx.doi.org/10.1186/s13046-019-1175-2] [PMID: 31046781]
[http://dx.doi.org/10.1093/abbs/gmz003] [PMID: 30883648]
[http://dx.doi.org/10.1016/j.canlet.2012.12.013] [PMID: 23268335]
[PMID: 32096160]
[http://dx.doi.org/10.2147/CMAR.S238172] [PMID: 32547198]
[http://dx.doi.org/10.3389/fgene.2021.779195] [PMID: 34976014]
[http://dx.doi.org/10.1186/s13046-020-01793-7] [PMID: 33308298]
[http://dx.doi.org/10.1002/jcb.26850] [PMID: 29741786]
[http://dx.doi.org/10.3892/ol.2020.11346] [PMID: 32194733]
[http://dx.doi.org/10.1167/iovs.61.6.41] [PMID: 32561925]
[http://dx.doi.org/10.2147/CMAR.S327211] [PMID: 34938119]
[http://dx.doi.org/10.2147/CMAR.S320616] [PMID: 34764698]
[http://dx.doi.org/10.1080/21691401.2020.1773486] [PMID: 32524841]
[http://dx.doi.org/10.1002/ijc.24146] [PMID: 19117056]
[http://dx.doi.org/10.1186/s12935-020-01221-y] [PMID: 32355466]
[http://dx.doi.org/10.18632/oncotarget.8629] [PMID: 27078844]
[http://dx.doi.org/10.1016/j.lfs.2020.117611] [PMID: 32243925]
[http://dx.doi.org/10.7150/jca.20879] [PMID: 29290781]